RelA is required for IL-1β stimulation of Matrix Metalloproteinase-1 expression in chondrocytes

Osteoarthritis and Cartilage

Volumn 15, Issue 4, 2007, Pages 431-441

  Raymond, L ^a,b   Eck, S ^b   Hays, E ^b   Tomek, I ^c   Kantor, S ^c   Vincenti, M ^a,b  

^a VA MEDICAL CENTER   (United States)

^b DARTMOUTH MEDICAL SCHOOL   (United States)

^c DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

Author keywords

Arthritis; Chondrocytes; Interleukin 1; Matrix Metalloproteinase 1; Nuclear factor kappa B

Indexed keywords

COLLAGEN TYPE 2; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERSTITIAL COLLAGENASE; MESSENGER RNA; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR RELA;

ARTICLE; ARTICULAR CARTILAGE; CARTILAGE CELL; CELL CULTURE; CELL LINE; CONTROLLED STUDY; GENE ACTIVATION; GENE EXPRESSION; GENE SILENCING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION; STEADY STATE; WESTERN BLOTTING;

AGGRECANS; ARTHRITIS; CELL CULTURE TECHNIQUES; CHONDROCYTES; COLLAGEN TYPE II; GENE EXPRESSION REGULATION; HUMANS; INTERLEUKIN-1BETA; MATRIX METALLOPROTEINASE 1; TRANSCRIPTION FACTOR RELA;

EID: 33847761165     PISSN: 10634584     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.joca.2006.09.011     Document Type: Article

References (40)

1. Burrage P.S., Mix K.S., and Brinckerhoff C.E. Matrix metalloproteinases: role in arthritis. Front Biosci 11 (2006) 529-543
2. Holmbeck K., Bianco P., Yamada S., and Birkedal-Hansen H. MT1-MMP: a tethered collagenase. J Cell Physiol 200 (2004) 11-19
3. Murphy G., Knauper V., Atkinson S., Butler G., English W., Hutton M., et al. Matrix metalloproteinases in arthritic disease. Arthritis Res 4 Suppl 3 (2002) S39-S49
4. Firestein G.S., Paine M.M., and Littman B.H. Gene expression (collagenase, tissue inhibitor of metalloproteinases, complement, and HLA-DR) in rheumatoid arthritis and osteoarthritis synovium. Quantitative analysis and effect of intraarticular corticosteroids. Arthritis Rheum 34 (1991) 1094-1105
5. Kevorkian L., Young D.A., Darrah C., Donell S.T., Shepstone L., Porter S., et al. Expression profiling of metalloproteinases and their inhibitors in cartilage. Arthritis Rheum 50 (2004) 131-141
6. Petrow P.K., Wernicke D., Schulze Westhoff C., Hummel K.M., Brauer R., Kriegsmann J., et al. Characterisation of the cell type-specificity of collagenase 3 mRNA expression in comparison with membrane type 1 matrix metalloproteinase and gelatinase A in the synovial membrane in rheumatoid arthritis. Ann Rheum Dis 61 (2002) 391-397
7. Shlopov B.V., Lie W.R., Mainardi C.L., Cole A.A., Chubinskaya S., and Hasty K.A. Osteoarthritic lesions: involvement of three different collagenases. Arthritis Rheum 40 (1997) 2065-2074
8. Tetlow L.C., Adlam D.J., and Woolley D.E. Matrix metalloproteinase and proinflammatory cytokine production by chondrocytes of human osteoarthritic cartilage: associations with degenerative changes. Arthritis Rheum 44 (2001) 585-594
9. Tetlow L.C., and Woolley D.E. Comparative immunolocalization studies of collagenase 1 and collagenase 3 production in the rheumatoid lesion, and by human chondrocytes and synoviocytes in vitro. Br J Rheumatol 37 (1998) 64-70
10. Tchetina E.V., Squires G., and Poole A.R. Increased type II collagen degradation and very early focal cartilage degeneration is associated with upregulation of chondrocyte differentiation related genes in early human articular cartilage lesions. J Rheumatol 32 (2005) 876-886
11. Wu W., Billinghurst R.C., Pidoux I., Antoniou J., Zukor D., Tanzer M., et al. Sites of collagenase cleavage and denaturation of type II collagen in aging and osteoarthritic articular cartilage and their relationship to the distribution of matrix metalloproteinase 1 and matrix metalloproteinase 13. Arthritis Rheum 46 (2002) 2087-2094
12. Poole A.R., Kobayashi M., Yasuda T., Laverty S., Mwale F., Kojima T., et al. Type II collagen degradation and its regulation in articular cartilage in osteoarthritis. Ann Rheum Dis 61 Suppl 2 (2002) ii78-ii81
13. Karin M., Yamamoto Y., and Wang Q.M. The IKK NF-kappa B system: a treasure trove for drug development. Nat Rev Drug Discov 3 (2004) 17-26
14. Baeuerle P.A., and Baltimore D. A 65-kappaD subunit of active NF-kappaB is required for inhibition of NF-kappaB by I kappaB. Genes Dev 3 (1989) 1689-1698
15. Sasaki C.Y., Barberi T.J., Ghosh P., and Longo D.L. Phosphorylation of RelA/p65 on serine 536 defines an I{kappa}B{alpha}-independent NF-{kappa}B pathway. J Biol Chem 280 (2005) 34538-34547
16. Vincenti M.P., and Brinckerhoff C.E. Transcriptional regulation of collagenase (MMP-1, MMP-13) genes in arthritis: integration of complex signaling pathways for the recruitment of gene-specific transcription factors. Arthritis Res 4 (2002) 157-164
17. Raymond L., Eck S., Mollmark J., Hays E., Tomek I., Kantor S., et al. Interleukin-1 beta induction of matrix metalloproteinase-1 transcription in chondrocytes requires ERK-dependent activation of CCAAT enhancer-binding protein-beta. J Cell Physiol 207 (2006) 683-688
18. Barchowsky A., Frleta D., and Vincenti M.P. Integration of the NF-kappaB and mitogen-activated protein kinase/AP-1 pathways at the collagenase-1 promoter: divergence of IL-1 and TNF-dependent signal transduction in rabbit primary synovial fibroblasts. Cytokine 12 (2000) 1469-1479
19. Bond M., Chase A.J., Baker A.H., and Newby A.C. Inhibition of transcription factor NF-kappaB reduces matrix metalloproteinase-1, -3 and -9 production by vascular smooth muscle cells. Cardiovasc Res 50 (2001) 556-565
20. Bondeson J., Brennan F., Foxwell B., and Feldmann M. Effective adenoviral transfer of IkappaBalpha into human fibroblasts and chondrosarcoma cells reveals that the induction of matrix metalloproteinases and proinflammatory cytokines is nuclear factor-kappaB dependent. J Rheumatol 27 (2000) 2078-2089
21. Mengshol J.A., Vincenti M.P., Coon C.I., Barchowsky A., and Brinckerhoff C.E. Interleukin-1 induction of collagenase 3 (matrix metalloproteinase 13) gene expression in chondrocytes requires p38, c-Jun N-terminal kinase, and nuclear factor kappaB: differential regulation of collagenase 1 and collagenase 3. Arthritis Rheum 43 (2000) 801-811
22. Elliott S.F., Coon C.I., Hays E., Stadheim T.A., and Vincenti M.P. Bcl-3 is an interleukin-1-responsive gene in chondrocytes and synovial fibroblasts that activates transcription of the matrix metalloproteinase 1 gene. Arthritis Rheum 46 (2002) 3230-3239
23. Vincenti M.P., and Brinckerhoff C.E. Early response genes induced in chondrocytes stimulated with the inflammatory cytokine interleukin-1beta. Arthritis Res 3 (2001) 381-388
24. Gebauer M., Saas J., Sohler F., Haag J., Soder S., Pieper M., et al. Comparison of the chondrosarcoma cell line SW1353 with primary human adult articular chondrocytes with regard to their gene expression profile and reactivity to IL-1beta. Osteoarthritis Cartilage 13 (2005) 697-708
25. Elliott S., Hays E., Mayor M., Sporn M., and Vincenti M. The triterpenoid CDDO inhibits expression of matrix metalloproteinase-1, matrix metalloproteinase-13 and Bcl-3 in primary human chondrocytes. Arthritis Res Ther 5 (2003) R285-R291
26. Rutter J.L., Benbow U., Coon C.I., and Brinckerhoff C.E. Cell-type specific regulation of human interstitial collagenase-1 gene expression by interleukin-1 beta (IL-1 beta) in human fibroblasts and BC-8701 breast cancer cells. J Cell Biochem 66 (1997) 322-336
27. Brown K., Gerstberger S., Carlson L., Franzoso G., and Siebenlist U. Control of I kappa B-alpha proteolysis by site-specific, signal-induced phosphorylation. Science 267 (1995) 1485-1488
28. Chen Z., Hagler J., Palombella V.J., Melandri F., Scherer D., Ballard D., et al. Signal-induced site-specific phosphorylation targets I kappa B alpha to the ubiquitin-proteasome pathway. Genes Dev 9 (1995) 1586-1597
29. Traenckner E.B., Pahl H.L., Henkel T., Schmidt K.N., Wilk S., and Baeuerle P.A. Phosphorylation of human I kappa B-alpha on serines 32 and 36 controls I kappa B-alpha proteolysis and NF-kappa B activation in response to diverse stimuli. Embo J 14 (1995) 2876-2883
30. Egan L.J., Mays D.C., Huntoon C.J., Bell M.P., Pike M.G., Sandborn W.J., et al. Inhibition of interleukin-1-stimulated NF-kappaB RelA/p65 phosphorylation by mesalamine is accompanied by decreased transcriptional activity. J Biol Chem 274 (1999) 26448-26453
31. Sitcheran R., Cogswell P.C., and Baldwin Jr. A.S. NF-kappaB mediates inhibition of mesenchymal cell differentiation through a posttranscriptional gene silencing mechanism. Genes Dev 17 (2003) 2368-2373
32. Kuhn K., Hashimoto S., and Lotz M. IL-1 beta protects human chondrocytes from CD95-induced apoptosis. J Immunol 164 (2000) 2233-2239
33. Franzoso G., Bours V., Azarenko V., Park S., Tomita-Yamaguchi M., Kanno T., et al. The oncoprotein Bcl-3 can facilitate NF-kappa B-mediated transactivation by removing inhibiting p50 homodimers from select kappa B sites. Embo J 12 (1993) 3893-3901
34. Brasier A.R., Lu M., Hai T., Lu Y., and Boldogh I. NF-kappa B-inducible BCL-3 expression is an autoregulatory loop controlling nuclear p50/NF-kappa B1 residence. J Biol Chem 276 (2001) 32080-32093
35. Chen L.F., Williams S.A., Mu Y., Nakano H., Duerr J.M., Buckbinder L., et al. NF-kappaB RelA phosphorylation regulates RelA acetylation. Mol Cell Biol 25 (2005) 7966-7975
36. Sun Y., Sun Y., Wenger L., Rutter J.L., Brinckerhoff C.E., and Cheung H.S. Human metalloproteinase-1 (collagenase-1) is a tumor suppressor protein p53 target gene. Ann N Y Acad Sci 878 (1999) 638-641
37. Sun Y., Zeng X.R., Wenger L., Firestein G.S., and Cheung H.S. P53 down-regulates matrix metalloproteinase-1 by targeting the communications between AP-1 and the basal transcription complex. J Cell Biochem 92 (2004) 258-269
38. Jeong S.J., Pise-Masison C.A., Radonovich M.F., Park H.U., and Brady J.N. A novel NF-kappaB pathway involving IKKbeta and p65/RelA Ser-536 phosphorylation results in p53 Inhibition in the absence of NF-kappaB transcriptional activity. J Biol Chem 280 (2005) 10326-10332
39. Yuan W., and Varga J. Transforming growth factor-beta repression of matrix metalloproteinase-1 in dermal fibroblasts involves Smad3. J Biol Chem 276 (2001) 38502-38510
40. Bitzer M., von Gersdorff G., Liang D., Dominguez-Rosales A., Beg A.A., Rojkind M., et al. A mechanism of suppression of TGF-beta/SMAD signaling by NF-kappa B/RelA. Genes Dev 14 (2000) 187-197